Pharmacy-based CRC screening programs using FIT can improve early detection, especially in underserved communities, with effective follow-up care. Patients prefer digital updates for negative results ...

Colon cancer is the second-deadliest cancer in America. It's not deadly because it's particularly hard to treat or because oncologists are bad at spotting it. In large part, it's because people aren't ...

Colorectal cancer incidence and mortality have increased among younger adults in recent years, with the most significant increase seen in those ages 40 to 49. Starting FIT screening early was tied to ...

Mailing fecal immunochemical tests (FIT) directly to patients significantly increased colorectal cancer screening rates compared to active choice approaches. The study involved 20,509 adults aged 45 ...

Review highlights gut microbiota dysbiosis as an emerging colorectal cancer risk factor, with microbial signatures, including Fusobacterium nucleatum, showing promise as non-invasive biomarkers to ...

A new analysis provided “strong” support for starting fecal immunochemical test (FIT) screening at ages 40-49 rather than at the currently recommended age of 50. An exploratory initiative that offered ...

Stool DNA testing climbed sharply after the pandemic began while colonoscopy and fecal immunochemical test use fell, a study of nearly 25 million privately insured Blue Cross Blue Shield beneficiaries ...

Historically, the gold standard for diagnosing colorectal cancer has been a colonoscopy. During the procedure, a thin tube with a camera is inserted into the rectum, which lets the doctor examine the ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...